The NIH DP2 activity code supports highly innovative research by new investigators in all areas of biomedical and behavioral research. NIH currently has three active DP2 Notices of Funding Opportunity (NOFO). We’ve summarized them for you below. It is always a good idea to speak with the program officers of these NOFOs to determine whether […]
I have received a lot of requests lately for help writing an NIH rebuttal, so it seems like a good time to talk about what they are and how to write one. Rebuttals seem to go in and out of vogue at NIH, and for whatever reason right now, many program officers (POs) are requesting
What is an NIH Rebuttal and When/How Do I Write One? Read More »
The NIH Director’s New Innovator Award (activity code DP2) supports Early-Stage Investigators (ESIs) who are pursuing highly innovative research that has the potential to have a major impact on areas relevant to NIH mission. Applications can be basic, translational, or clinical in nature. The Notice of Funding Opportunity (RFA-RM-25-002) allows for clinical trials, though it
Spotlight on the NIH Director’s New Innovator Award – DP2 Read More »
